A Role of the Ah Receptor in Hematopoiesis: Model Characterization
A Role of the Ah Receptor in Hematopoiesis: Model Characterization
批准号:
7581310
负责人:
Thomas A Gasiewicz
金额:
$7.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-01 至 2011-01-31
关键词:
Activities of Daily LivingAddressAdolescentAgeAging-Related ProcessAllelesAnimalsAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorAutoimmune DiseasesBindingBlood CellsBone MarrowBone Marrow TransplantationCell CycleCell LineageCellsCharacteristicsChemical ActionsClinicalDataDevelopmentDioxinsDiseaseEquilibriumEventExhibitsExposure toFlow CytometryGenesHematopoiesisHematopoieticHematopoietic stem cellsHumanHydrocarbonsIncidenceKineticsLinkMalignant NeoplasmsMediatingModelingMusPancytopeniaPhysiologicalPlayPopulationPreventionProcessReceptor ActivationRegulationRoleSpecificityStem cellsStressTestingTransplantationaryl hydrocarbon receptor ligandcancer therapyexposed human populationgenetic regulatory proteinin vivoleukemialeukemia/lymphomamouse modelpublic health relevancereceptorreconstitutionregenerativeself-renewalstemtranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human exposures to polycyclic aromtic hydrocarbons and dioxins have been linked to the development of lymphomas and leukemias. The actions of these chemicals are mediated by a gene regulatory protein, the aryl hydrocarbon receptor (AhR). Persistent AhR activation in mice results in altered numbers and function of hematopoietic stem cells (HSCs). Preliminary data from Ahr null-allele (AhR-KO) mice also provides evidence to indicate that the AhR has a physiological role in the regulation of HSCs. The overall hypothesis is that AhR dysregulation plays a role in a number of hematopoietic disorders including leukemia. In this proposal we will begin to test the specific hypothesis that the AhR has an important role in the self-renewal and proliferation of HSCs. To do this, it is necessary to further define the phenotypic and functional characteristics of HSCs in AhR-KO mice. Using this mouse model and a variety of flow cytometry approaches, we will determine if HSCs in AhR-KO mice have high proliferation rates in vivo, and will identify the specific phenotypically-defined cell populations exhibiting this characteristic. We will also define the multi-lineage developmental potential of these cells under hematopoietic stress conditions. In a second aim, we will assess by primary and serial transplantation, the ability and kinetics of HSCs from AhR-KO mice for multi-lineage reconstitution. PUBLIC HEALTH RELEVANCE: The further understanding of the processes regulating HSC self-renewal and differentiation are fundamental to the prevention and treatment of a variety of leukemias and other hematopoietic diseases in humans. Understanding what regulates the normally incredible regenerative capacity of bone marrow also has clinical implications for bone marrow transplantation, autoimmune disease, and bone marrow failure that may be associated with cancer treatment. Furthermore, these events are intimately tied with the process of aging and a variety of diseases, including cancer, whose incidence increases with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:8556514
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2013
-
负责人:Thomas A Gasiewicz
-
依托单位:
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:8711463
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2013
-
负责人:Thomas A Gasiewicz
-
依托单位:
Strategic Vision & Impact on Environmental Health
-
批准号:8245860
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
-
批准号:8189491
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
-
批准号:8332788
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
Center Director
-
批准号:8245862
-
项目类别:
-
资助金额:$5.23万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
A Role of the Ah Receptor in Hematopoiesis: Model Characterization
-
批准号:7763260
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2009
-
负责人:Thomas A Gasiewicz
-
依托单位:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
-
批准号:7487558
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2007
-
负责人:Thomas A Gasiewicz
-
依托单位:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
-
批准号:7293745
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2007
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Inhibits AhR and Carcinogenesis by Modulating Hsp90
-
批准号:7014379
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2006
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Inhibits AhR and Carcinogenesis by Modulating Hsp90
-
批准号:7229822
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2006
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Community Outreach and Education Program
-
批准号:6868523
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2005
-
负责人:Thomas A Gasiewicz
-
依托单位:
Administrative Core
-
批准号:6868521
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2005
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Protein modulators of toxicity
-
批准号:6576566
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2002
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6576569
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2002
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6495635
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Protein modulators of toxicity
-
批准号:6441457
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Protein modulators of toxicity
-
批准号:6495632
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6441460
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6361482
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2000
-
负责人:Thomas A Gasiewicz
-
依托单位:
海外基金